Codexis, Inc. ( CDXS) - Key Metrics
CDXS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.43 | $0.11 | $0.22 | $0.22 |
| 2025Q3 | $0.10 | -$0.22 | -$0.09 | -$0.09 |
| 2025Q2 | $0.18 | -$0.16 | -$0.21 | -$0.24 |
| 2025Q1 | $0.09 | -$0.25 | -$0.17 | -$0.18 |
CDXS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 3.84 |
| 2025Q3 | ? | -2.81 |
| 2025Q2 | ? | -3.92 |
| 2025Q1 | ? | -2.68 |
CDXS
Price: $2.48
52 week price:
Earnings Per Share: -0.35 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 517700
Ebitda: -9.8 millionMarket Capitalization: 254.5 million